215 related articles for article (PubMed ID: 8622864)
1. Regulation of nov by WT1: a potential role for nov in nephrogenesis.
Martinerie C; Chevalier G; Rauscher FJ; Perbal B
Oncogene; 1996 Apr; 12(7):1479-92. PubMed ID: 8622864
[TBL] [Abstract][Full Text] [Related]
2. novH: differential expression in developing kidney and Wilm's tumors.
Chevalier G; Yeger H; Martinerie C; Laurent M; Alami J; Schofield PN; Perbal B
Am J Pathol; 1998 Jun; 152(6):1563-75. PubMed ID: 9626060
[TBL] [Abstract][Full Text] [Related]
3. [Genetic alterations associated with pathologic differentiation of Wilms' tumors].
Chevalier G; Perbal B
Bull Cancer; 1997 Mar; 84(3):289-303. PubMed ID: 9207876
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional repression of the insulin-like growth factor I receptor (IGF-I-R) gene by the tumor suppressor WT1 involves binding to sequences both upstream and downstream of the IGF-I-R gene transcription start site.
Werner H; Rauscher FJ; Sukhatme VP; Drummond IA; Roberts CT; LeRoith D
J Biol Chem; 1994 Apr; 269(17):12577-82. PubMed ID: 8175666
[TBL] [Abstract][Full Text] [Related]
5. Structural analysis of the human nov proto-oncogene and expression in Wilms tumor.
Martinerie C; Huff V; Joubert I; Badzioch M; Saunders G; Strong L; Perbal B
Oncogene; 1994 Sep; 9(9):2729-32. PubMed ID: 7520150
[TBL] [Abstract][Full Text] [Related]
6. Altered expression of novH is associated with human adrenocortical tumorigenesis.
Martinerie C; Gicquel C; Louvel A; Laurent M; Schofield PN; Le Bouc Y
J Clin Endocrinol Metab; 2001 Aug; 86(8):3929-40. PubMed ID: 11502835
[TBL] [Abstract][Full Text] [Related]
7. Differential function of Wilms' tumor gene WT1 splice isoforms in transcriptional regulation.
Hewitt SM; Fraizer GC; Wu YJ; Rauscher FJ; Saunders GF
J Biol Chem; 1996 Apr; 271(15):8588-92. PubMed ID: 8621487
[TBL] [Abstract][Full Text] [Related]
8. Contribution of MAV-1-induced nephroblastoma to the study of genes involved in human Wilms' tumor development.
Perbal B
Crit Rev Oncog; 1994; 5(6):589-613. PubMed ID: 8519812
[TBL] [Abstract][Full Text] [Related]
9. Regulation of insulin-like growth factor I receptor gene expression by the Wilms' tumor suppressor WT1.
Werner H; Roberts CT; Rauscher FJ; LeRoith D
J Mol Neurosci; 1996; 7(2):111-23. PubMed ID: 8873895
[TBL] [Abstract][Full Text] [Related]
10. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
[TBL] [Abstract][Full Text] [Related]
11. Identification of connective tissue growth factor as a target of WT1 transcriptional regulation.
Stanhope-Baker P; Williams BR
J Biol Chem; 2000 Dec; 275(49):38139-50. PubMed ID: 10973960
[TBL] [Abstract][Full Text] [Related]
12. The Wilms' tumor gene WT1 can regulate genes involved in sex determination and differentiation: SRY, Müllerian-inhibiting substance, and the androgen receptor.
Shimamura R; Fraizer GC; Trapman J; Lau YfC ; Saunders GF
Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2571-80. PubMed ID: 9815658
[TBL] [Abstract][Full Text] [Related]
13. Human platelet-derived growth factor A chain is transcriptionally repressed by the Wilms tumor suppressor WT1.
Gashler AL; Bonthron DT; Madden SL; Rauscher FJ; Collins T; Sukhatme VP
Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10984-8. PubMed ID: 1332065
[TBL] [Abstract][Full Text] [Related]
14. PAX 8 regulates human WT1 transcription through a novel DNA binding site.
Fraizer GC; Shimamura R; Zhang X; Saunders GF
J Biol Chem; 1997 Dec; 272(49):30678-87. PubMed ID: 9388203
[TBL] [Abstract][Full Text] [Related]
15. Products of alternatively spliced transcripts of the Wilms' tumor suppressor gene, wt1, have altered DNA binding specificity and regulate transcription in different ways.
Wang ZY; Qiu QQ; Huang J; Gurrieri M; Deuel TF
Oncogene; 1995 Feb; 10(3):415-22. PubMed ID: 7845666
[TBL] [Abstract][Full Text] [Related]
16. Repression of the transforming growth factor-beta 1 gene by the Wilms' tumor suppressor WT1 gene product.
Dey BR; Sukhatme VP; Roberts AB; Sporn MB; Rauscher FJ; Kim SJ
Mol Endocrinol; 1994 May; 8(5):595-602. PubMed ID: 8058069
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional repression of human insulin-like growth factor-II P4 promoter by Wilms' tumor suppressor WT1.
Lee YI; Kim SJ
DNA Cell Biol; 1996 Feb; 15(2):99-104. PubMed ID: 8634146
[TBL] [Abstract][Full Text] [Related]
18. Proto-oncogene N-myc promoter is down regulated by the Wilms' tumor suppressor gene WT1.
Zhang X; Xing G; Saunders GF
Anticancer Res; 1999; 19(3A):1641-8. PubMed ID: 10470095
[TBL] [Abstract][Full Text] [Related]
19. Sp1 is a critical regulator of the Wilms' tumor-1 gene.
Cohen HT; Bossone SA; Zhu G; McDonald GA; Sukhatme VP
J Biol Chem; 1997 Jan; 272(5):2901-13. PubMed ID: 9006935
[TBL] [Abstract][Full Text] [Related]
20. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]